BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference

  Vistagen today announced that it will present posters at the American Society of Clinical Psychopharmacology Conference in Miami Beach, Florida from May 28 to 31, 2024.

  May 23, 2024

   · 

  6 min read
• Immorta Bio Inc, a Longevity Company, Announces a Significant Breakthrough in Treatment of Liver Failure

  Immorta Bio Inc, a science-based Life Extension company has announced patent filing on successful treatment of the carbon tetrachloride model of liver failure using its PMSC-11 stem cell therapy.

  May 23, 2024

   · 

  3 min read
• Business

  CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

  CureVac N.V. (Nasdaq:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced financial results for the first quarter of 2024 and provided a business update.

  May 23, 2024

   · 

  12 min read
• Pharmadrug’s Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine

  PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances

  May 23, 2024

   · 

  7 min read
• BioMidwest

  Express Scripts enhances strategies to support access to care at independent pharmacies

  Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.

  May 23, 2024

   · 

  3 min read
• FDA

  Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer

  Theriva™ Biologics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to lead clinical candidate VCN-01.

  May 23, 2024

   · 

  7 min read
• Pharm Country

  Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

  Eisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), which is taking place virtually and in-person in Chicago, Illinois from May 31 to June 4.

  May 23, 2024

   · 

  32 min read
• FDA

  Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147

  Abdera Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for ABD-147.

  May 23, 2024

   · 

  5 min read
• Biotech Bay

  Twist Bioscience to Present at Upcoming Investor Conferences-May 23, 2024

  Twist Bioscience Corporation today announced that its executives will present and participate in fireside chats at the following upcoming investor conferences.

  May 23, 2024

   · 

  2 min read
• Drug Development

  Mythic Therapeutics to Present Data from Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting

  Mythic Therapeutics today announced that it will present initial dose escalation results from its Phase 1 KisMET-01 study evaluating its investigational cMET-targeting ADC, MYTX-011.

  May 23, 2024

   · 

  2 min read